Articles from David Sterman, StreetAuthority Investor Update

About David Sterman, StreetAuthority Investor Update

David Sterman has worked as an investment analyst for nearly two decades. David has served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.

Forget Oil And Gas — This Commodity Is Poised To Rally

Forget Oil And Gas — This Commodity Is Poised To Rally

All across Europe, power companies are being forced to mothball natural-gas power plants. In just the past few weeks, renewable-energy companies such as Germany’s E.ON and Norway’s Statkraft have done so as well, as a key dynamic... read more »

 

Are These The Breakout Dividend Stars Of 2014?

Are These The Breakout Dividend Stars Of 2014?

Year after year, credit card processor MasterCard (NYSE: MA) paid out a simple annual dividend of 60 cents a share. Management thought the payment was a nice gesture to investors, but not really noteworthy in the context of a triple-digit stock... read more »

 

Shares Of This Well-Known Smartphone Maker Could Drop 30%

Shares Of This Well-Known Smartphone Maker Could Drop 30%

Everyone loves a good turnaround story. This is especially true for investors when it comes to turnaround stocks. These often-scorned investments can prove a host of doubters wrong and deliver stunning upside as remaining bears turn back into... read more »

 

How You Can Profit From The $1 Billion Buyback Playbook

How You Can Profit From The $1 Billion Buyback Playbook

Here at StreetAuthority, we spend a great deal of time focusing on dividend-paying stocks. Rising dividend payments have become the hallmark of the modern investing era as companies begin to return unneeded cash back to its rightful owners —... read more »

 

Are These The Biotech Stars Of Tomorrow?

Are These The Biotech Stars Of Tomorrow?

In the past 30 years, hundreds of thousands of people have been given a second chance after battling cancer. Many of these cancer survivors have long been in remission, but there’s still reason for concern. Cancer kills more than 500,000... read more »

 

Invest In The War On Cancer With These Stocks

Invest In The War On Cancer With These Stocks

I recently heard from an old friend. He told me of his battle with colon cancer. His doctors had given him a 30% chance of surviving, but thanks a new generation of powerful anti-cancer drugs, his cancer has been in remission for nearly five... read more »

 

Tourism Is Booming — Here’s How To Profit

Tourism Is Booming — Here’s How To Profit

As we head toward Memorial Day weekend, summer travel plans are being discussed around many kitchen tables. Americans are hitting the road again, packing hotels in major cities as some national parks brace for a record number of visitors. Many... read more »

 

15 Stocks That Hit The ‘Deep-Value Trifecta’

15 Stocks That Hit The ‘Deep-Value Trifecta’

Value investors tend to favor specific gauges to find bargains. Some like to seek out stocks trading below tangible book value, while others seek out stocks that sport low price-to-earnings (P/E) multiples or impressive free cash flow characteristics. But... read more »

 

A $100 Billion Cannon Is Pointed At These Takeover Targets

A $100 Billion Cannon Is Pointed At These Takeover Targets

Back in 2006, the U.S. economy was growing at a solid clip, the stock market was on the rise, and big investors such as pension funds were looking for ways to boost returns. The most appealing destination for these investors was private equity. Private... read more »

 

The Underappreciated Metric That Spotlights Bargain Stocks

The Underappreciated Metric That Spotlights Bargain Stocks

We live in a yield-obsessed era. Whether it’s dividend yields, junk bond yields or lowly government bond yields, investors seek yields in every corner of the market. But many overlook the most important type: free cash flow yield. It’s... read more »